Revenue (Tables)

12 Months Ended

Dec. 31, 2024

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregated Revenue

The following table presents our disaggregated revenue for the periods presented (in thousands):

	Year Ended December 31,
	2024		2023		2022
MRD revenue
Service revenue	$	133,029	$	102,739	$	81,144
Regulatory milestone revenue		12,500		—		6,000
Total MRD revenue		145,529		102,739		87,144
Immune Medicine revenue
Service revenue		19,976		24,959		31,777
Collaboration revenue		13,452		42,578		66,387
Total Immune Medicine revenue		33,428		67,537		98,164
Total revenue	$	178,957	$	170,276	$	185,308